Risankizumab as a Therapeutic Approach for Recalcitrant Pyoderma Gangrenosum.

Pyoderma gangrenosum (PG) is a neutrophilic dermatosis that is challenging to diagnose and treat. Clinicians frequently use fast-acting corticosteroids, which are subsequently combined with slower-acting immunosuppressants to progressively taper the corticosteroid dosage. Current research is focused...

Descripción completa

Detalles Bibliográficos

Publicado en:	Advances in Skin & Wound Care Vol. 37; no. 5; pp. 276 - 280
Autores principales:	Michelucci, Alessandra, Manzo Margiotta, Flavia, Granieri, Giammarco, Salvia, Giorgia, Fidanzi, Cristian, Bevilacqua, Matteo, Panduri, Salvatore, Romanelli, Marco, Dini, Valentina
Formato:	case study pictorial Journal Article
Publicado:	Lippincott Williams & Wilkins May2024
Acceso en línea:	Ver este registro en EBSCOhost